Heart Test Laboratories Has Been Granted European Patent Number EP3834729 Titled "ELECTROCARDIOGRAM-BASED ASSESSMENT OF DIASTOLIC FUNCTION"
Portfolio Pulse from Benzinga Newsdesk
Heart Test Laboratories has been granted European Patent Number EP3834729 for its technology titled 'ELECTROCARDIOGRAM-BASED ASSESSMENT OF DIASTOLIC FUNCTION'.
May 22, 2024 | 3:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Heart Test Laboratories has been granted a European patent for its ECG-based diastolic function assessment technology, which could enhance its product offerings and market position.
The granting of a European patent for Heart Test Laboratories' ECG-based diastolic function assessment technology is a significant milestone. It strengthens the company's intellectual property portfolio and could lead to enhanced product offerings and a stronger market position, potentially driving short-term stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100